Email Page Print Page

Publications

Seeking additional clinical resources? This section offers a list of clinical studies and articles related to MammoSite 5-Day Targeted Radiation Therapy, breast brachytherapy, and the treatment of breast cancer. With this guide you should be able to easily find additional clinical and disease information.

Clinical Studies

Arthur DW, Vicini FA. MammoSite RTS: the reporting of initial experiences and how to interpret. Ann Surg Oncol 2004;11:723-4.

Astrahan MA. HDR quality assurance methods for personal digital assistants. Med Dosim 2004;29:166-72.

Astrahan MA, Jozsef G, Streeter OE, Jr. Optimization of MammoSite therapy. Int J Radiat Oncol Biol Phys 2004;58:220-32.

Azria D, Hennequin C. [Impact of radiotherapy modalities on local control and survival in adjuvant breast cancer treatment.]. Cancer Radiother 2009.

Beitsch PD, Hodge CW, Dowlat K, Francescatti D, Gittleman MA, Israel P, et al. The surgeon's role in breast brachytherapy. Breast J 2009;15:93-100.

Belkacemi Y, Chauvet MP, Giard S, Poupon L, Castellanos ME, Villette S, et al. [Partial breast irradiation: high dose rate peroperative brachytherapy technique using the MammoSite]. Cancer Radiother 2003;7 Suppl 1:129s-36s.

Belkacemi Y, Chauvet MP, Giard S, Villette S, Lacornerie T, Bonodeau F, et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol 2009;90:23-9.

Belkacemi Y, Vicini F. High-dose brachytherapy using MammoSite applicator: "Our doubts are traitors, and makes us lose the good we oft might win, by fearing to attempt !". Radiother Oncol 2007;82:354-5; author reply 5-6.

Benitez PR, Keisch ME, Vicini F, Stolier A, Scroggins T, Walker A, et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 2007;194:456-62.

Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, et al. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg 2006;192:427-33.

Bensaleh S, Bezak E, Borg M. Review of MammoSite brachytherapy: advantages, disadvantages and clinical outcomes. Acta Oncol 2009;48:487-94.

Borg M, Yeoh E, Bochner M, Butters J, van Doorn T, Farshid G, et al. Feasibility study on the MammoSite in early-stage breast cancer: initial experience. Australas Radiol 2007;51:53-61.

Brashears JH, Dragun AE, Jenrette JM. Late chest wall toxicity after MammoSite breast brachytherapy. Brachytherapy 2009;8:19-25.

Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience. Int J Radiat Oncol Biol Phys 2007;69:32-40.

Chen PY, Vicini FA. Partial breast irradiation. Patient selection, guidelines for treatment, and current results. Front Radiat Ther Oncol 2007;40:253-71.

Cheng CW, Mitra R, Li XA, Das IJ. Dose perturbations due to contrast medium and air in mammosite treatment: an experimental and Monte Carlo study. Med Phys 2005;32:2279-87.

Chopra S. In regards to Dickler et al.: Treatment volume and dose optimization of mammosite breast brachytherapy applicator (Int J Radiat Oncol Biol Phys 2004;59:469-474). Int J Radiat Oncol Biol Phys 2005;61:630; author reply -1.

Cuttino LW, Keisch M, Jenrette JM, Dragun AE, Prestidge BR, Quiet CA, et al. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results. Int J Radiat Oncol Biol Phys 2008;71:107-14.

Cuttino LW, Todor D, Rosu M, Arthur DW. Skin and chest wall dose with multi-catheter and MammoSite breast brachytherapy: Implications for late toxicity. Brachytherapy 2009;8:223-6.

Dickler A. The MammoSite breast brachytherapy device: targeted delivery of breast brachytherapy. Future Oncol 2005;1:799-804.

Dickler A. Technology insight: MammoSite--a new device for delivering brachytherapy following breast-conserving therapy. Nat Clin Pract Oncol 2007;4:190-6.

Dickler A, Khan AJ. Accelerated partial breast irradiation using the MammoSite device. Nat Clin Pract Oncol 2007;4:324-5.

Dickler A, Kirk M, Choo J, Hsi WC, Chu J, Dowlatshahi K, et al. Treatment volume and dose optimization of MammoSite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2004;59:469-74.

Dickler A, Kirk MC, Choo J, Hsi WC, Chu J, Dowlatshahi K, et al. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator. Breast J 2005;11:306-10.

Dickler A, Kirk MC, Chu J, Nguyen C. The MammoSite breast brachytherapy applicator: a review of technique and outcomes. Brachytherapy 2005;4:130-6.

DiFronzo LA, Tsai PI, Hwang JM, Lee JJ, Ryoo MC, Rahimian J, et al. Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: initial clinical experience. Arch Surg 2005;140:787-94.

Dragun AE, Aguero EG, Harmon JF, Harper JL, Jenrette JM. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy 2005;4:259-63.

Dragun AE, Harper JL, Jenrette JM, Sinha D, Cole DJ. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys 2007;68:354-8.

Dragun AE, Harper JL, Taylor CE, Jenrette JM. Patient satisfaction and quality of life after MammoSite breast brachytherapy. Am J Surg 2008;196:545-8.

Dragun AE, Jenrette JM, Ackerman SJ, Irshad A, Pope TL. Mammographic surveillance after MammoSite breast brachytherapy: analysis of architectural patterns and additional interventions. Am J Clin Oncol 2007;30:574-9.

Edmundson GK, Vicini FA, Chen PY, Mitchell C, Martinez AA. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2002;52:1132-9.

Evans SB, Kaufman SA, Price LL, Cardarelli G, Dipetrillo TA, Wazer DE. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing factors. Int J Radiat Oncol Biol Phys 2006;65:333-9.

Forszpaniak J. MammoSite balloon brachytherapy: errors, pitfalls, and technical issues for a practicing surgeon. Breast J 2006;12:S191-5.

Garnica-Garza HM. Monte Carlo-derived TLD cross-calibration factors for treatment verification and measurement of skin dose in accelerated partial breast irradiation. Phys Med Biol 2009;54:1621-31.

Garza R, Albuquerque K, Sethi A. Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields. Brachytherapy 2006;5:235-8.

Gennari R, Perego E, Ballardini B, dos Santos G, Costa A. Surgical technique of mammosite RTS implant for accelerated radiation delivery in breast conserving surgery. J Exp Clin Cancer Res 2004;23:411-5.

Goyal S, Khan AJ, Vicini F, Beitsch PD, Lyden M, Keisch M, et al. Factors Associated with Optimal Cosmetic Results at 36 Months in Patients Treated with Accelerated Partial Breast Irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite((R)) Breast Brachytherapy Registry Trial. Ann Surg Oncol 2009.

Haffty BG, Vicini FA, Beitsch P, Quiet C, Keleher A, Garcia D, et al. Timing of Chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Int J Radiat Oncol Biol Phys 2008;72:1441-8.

Haley M, Beriwal S, Heron DE, Kim H, Falk J, Johnson R, et al. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup. Brachytherapy 2009;8:9-13.

Hannoun-Levi JM, Marsiglia H, Garbay JR, Gerard JP. [Partial irradiation of the breast: why, how?]. Cancer Radiother 2003;7:200-9.

Harper JL, Jenrette JM. Delayed skin toxicity in MammoSite breast brachytherapy. Am J Clin Oncol 2006;29:645-6.

Harper JL, Jenrette JM, Vanek KN, Aguero EG, Gillanders WE. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys 2005;61:169-74.

Hogle WP, Quinn AE, Heron DE. Advances in brachytherapy: new approaches to target breast cancer. Clin J Oncol Nurs 2003;7:324-8.

Jeruss JS, Vicini FA, Beitsch PD, Haffty BG, Quiet CA, Zannis VJ, et al. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Ann Surg Oncol 2006;13:967-76.

Kacso G, Fekete Z. Adjuvant partial breast radiotherapy for early breast cancer--ready for a change? J BUON 2008;13:169-75.

Kassas B, Mourtada F, Horton JL, Lane RG. Contrast effects on dosimetry of a partial breast irradiation system. Med Phys 2004;31:1976-9.

Kaufman SA, Dipetrillo TA, Ruthazer R, Wazer DE. MammoSite excision volume as a predictor for residual disease. Cancer 2005;104:906-12.

Keisch M, Arthur DW. Current perspective on the MammoSite Radiation Therapy System - a balloon breast brachytherapy applicator. Brachytherapy 2005;4:177-80.

Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003;55:289-93.

Khan AJ, Vicini F, Beitsch P, Haffty B, Quiet C, Keleher A, et al. Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial. Ann Surg Oncol 2009;16:1612-8.

Kim Y, Johnson M, Trombetta MG, Parda DS, Miften M. Investigation of interfraction variations of MammoSite balloon applicator in high-dose-rate brachytherapy of partial breast irradiation. Int J Radiat Oncol Biol Phys 2008;71:305-13.

Kirk M, Hsi WC, Dickler A, Chu J, Dowlatshahi K, Francescatti D, et al. Surface optimization technique for MammoSite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2005;62:366-72.

Kirk MC, Hsi WC, Chu JC, Niu H, Hu Z, Bernard D, et al. Dose perturbation induced by radiographic contrast inside brachytherapy balloon applicators. Med Phys 2004;31:1219-24.

Lopchinsky RA, Giles KA. Recurrent abscess after MammoSite brachytherapy. Breast J 2004;10:536-8.

Major T, Niehoff P, Kovacs G, Fodor J, Polgar C. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer. Radiother Oncol 2006;79:321-8.

Malik Z, Lee CD, Snee A, Brown L, Magennis J, Swe F, et al. Partial Breast Irradiation for Early Stage Breast Cancer using the Mammosite((R)) Catheter. Clin Oncol (R Coll Radiol) 2007;19:S17-8.

McCormick B. Partial-breast radiation for early staged breast cancers: hypothesis, existing data, and a planned phase III trial. J Natl Compr Canc Netw 2005;3:301-7.

Moore-Higgs GJ. Radiation options for early stage breast cancer. Semin Oncol Nurs 2006;22:233-41.

Mutyala S, Choi W, Khan AJ, Yaparpalvi R, Stewart AJ, Devlin PM. Inherent change in MammoSite applicator three-dimensional geometry over time. Radiat Oncol 2007;2:37.

Mutyala S, Yaparpalvi R, Choi W, Mehta K, Spierer M, Kalnicki S. Placement of MammoSite(r) Brachytherapy Catheter Under Computed-Tomography Scan Guidance. Technol Cancer Res Treat 2009;8:177-80.

Nelson JC, Beitsch PD, Vicini FA, Quiet CA, Garcia D, Snider HC, et al. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Am J Surg 2009;198:83-91.

Niehoff P, Ballardini B, Polgar C, Major T, Hammer J, Richetti A, et al. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer. Breast 2006;15:319-25.

Niehoff P, Polgar C, Ostertag H, Major T, Sulyok Z, Kimmig B, et al. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol 2006;79:316-20.

RR, Christensen ME, Hodge CW, Adkison JB, Das RK. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results. Int J Radiat Oncol Biol Phys 2008;70:970-3.

Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 2004;11:739-46.

Sadeghi A, Prestidge B, Lee JM, Rosenthal A. Evaluation of the surface radiation dose and dose gradient in early stage breast cancer using high-dose-rate brachytherapy MammoSite applicator. Brachytherapy 2006;5:230-4.

Sarin R. Partial-breast treatment for early breast cancer: emergence of a new paradigm. Nat Clin Pract Oncol 2005;2:40-7.

Sauer G, Strnad V, Kurzeder C, Kreienberg R, Sauer R. Partial breast irradiation after breast-conserving surgery. Strahlenther Onkol 2005;181:1-8.

Sauer R, Sautter-Bihl ML, Budach W, Feyer P, Harms W, Souchan R, et al. Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies. Cancer 2007;110:1187-94.

Selvaraj RN, Bhatnagar A, Beriwal S, Huq MS, Heron DE, Sonnik D, et al. Breast skin doses from brachytherapy using MammoSite HDR, intensity modulated radiation therapy, and tangential fields techniques. Technol Cancer Res Treat 2007;6:17-22.

Shah AP, Dickler A, Kirk MC, Chen SS, Strauss JB, Coon AB, et al. Case report and dosimetric analysis of an axillary recurrence after partial breast irradiation with mammosite catheter. Med Dosim 2008;33:222-5.

Shah NM, Tenenholz T, Arthur D, DiPetrillo T, Bornstein B, Cardarelli G, et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer 2004;101:727-34.

Shah NM, Wazer DE. The MammoSite balloon brachytherapy catheter for accelerated partial breast irradiation. Semin Radiat Oncol 2005;15:100-7.

Sher DJ, Wittenberg E, Suh WW, Taghian AG, Punglia RS. Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys 2009;74:440-6.

Soran A, Evrensel T, Beriwal S, Mogus R, Keenan D, Kelley JL, et al. Placement technique and the early complications of balloon breast brachytherapy: Magee-Womens Hospital experience. Am J Clin Oncol 2007;30:152-5.

Stewart AJ, O'Farrell DA, Cormack RA, Hansen JL, Khan AJ, Mutyala S, et al. Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. Radiat Oncol 2008;3:39.

Stolier AJ, Fuhrman GM, Scroggins TG, Boyer CI. Postlumpectomy Insertion of the MammoSite brachytherapy device using the scar entry technique: initial experience and technical considerations. Breast J 2005;11:199-203.

Strauss JB, Dickler A. Accelerated partial breast irradiation utilizing balloon brachytherapy techniques. Radiother Oncol 2009;91:157-65.

Streeter OE, Jr., Vicini FA, Keisch M, Astrahan MA, Jozsef G, Silverstein M, et al. MammoSite radiation therapy system. Breast 2003;12:491-6.

Suh WW, Pierce LJ, Vicini FA, Hayman JA. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2005;62:790-6.

Swanson TA, Vicini FA. Overview of accelerated partial breast irradiation. Curr Oncol Rep 2008;10:54-60.

Thompson N, Cogen C, Forman D, Londerville S. MammoSite Radiation Therapy System. Clin J Oncol Nurs 2005;9:375-7.

Trombetta M, Julian T, Miften M, McWilliams W, Kim Y, Parda D. The use of the MammoSite balloon applicator in re-irradiation of the breast. Brachytherapy 2008;7:316-9.

Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, et al. Long-term Cosmesis After Lumpectomy and Brachytherapy in the Management of Carcinoma of the Previously Irradiated Breast. Am J Clin Oncol 2009.

Tsai PI, Ryan M, Meek K, Ryoo MC, Tome M, Takasugi J, et al. Accelerated partial breast irradiation using the MammoSite device: early technical experience and short-term clinical follow-up. Am Surg 2006;72:929-34.

Vicini F, Beitsch PD, Quiet CA, Keleher AJ, Garcia D, Snider HC, Jr., et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 2008;112:758-66.

Vicini FA, Beitsch PD, Quiet CA, Keleher A, Garcia D, Snider HC, et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 2005;104:1138-48.

Voth M, Budway R, Keleher A, Caushaj PF. Local recurrence of breast cancer after MammoSite brachytherapy. Am Surg 2006;72:798-800; discussion -1.

Watkins JM, Harper JL, Dragun AE, Ashenafi MS, Sinha D, Li J, et al. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy 2008;7:305-9.

Weed DW, Edmundson GK, Vicini FA, Chen PY, Martinez AA. Accelerated partial breast irradiation: a dosimetric comparison of three different techniques. Brachytherapy 2005;4:121-9.

White J. MammoSite and accelerated partial breast irradiation: Rethinking one-size-fits-all breast irradiation after lumpectomy. Brachytherapy 2005;4:183-5.

Wilkinson JB, Boyle T, Song J, Kilbride K, Miltenburg D. Surgeon-performed ultrasound reliably predicts skin spacing and may decrease the rate of MammoSite balloon catheter explantation in patients undergoing brachytherapy for breast cancer. Am J Surg 2008;196:289-92.

Wojcicka JB, Lasher DE, Malcom R, Fortier G. Clinical and dosimetric experience with MammoSite-based brachytherapy under the RTOG 0413 protocol. J Appl Clin Med Phys 2007;8:2654.

Zannis V, Beitsch P, Vicini F, Quiet C, Keleher A, Garcia D, et al. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Am J Surg 2005;190:530-8.

Zannis VJ, Walker LC, Barclay-White B, Quiet CA. Postoperative ultrasound-guided percutaneous placement of a new breast brachytherapy balloon catheter. Am J Surg 2003;186:383-5.

Zhang Z, Parsai EI, Feldmeier JJ. Three-dimensional quantitative dose reduction analysis in MammoSite balloon by Monte Carlo calculations. J Appl Clin Med Phys 2007;8:2669

Back to Top